Sort
53,477 grants matching “addiction”
The Effect of Exercise on Acute Nicotine Withdrawal: Human Study
$512,038Isabella Soreca · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DA
Phosphoinositide Signaling at the Synapse
$511,995Johns Hopkins University · P50 · FY2004 · MH
Oregon's Coordinated Care Organizations Integrate Care for Drug Use Disorders
$511,990Dennis McCarty · Oregon Health & Science University · R33 · FY2014 · DA
Structure of the GABA-A Receptor Binding Sites
$511,989Cynthia M Czajkowski · University Of Wisconsin-Madison · R01 · FY2013 · NS
CULTURALLY CENTERED TREATMENT FOR OUD IMPLEMENTATION FOR ADDICTION TREATMENT PROGRAMS SERVING AMERICAN INDIAN/ALASKA NATIVES (CTN-0096). DSC5 CONTRACT. 09/20/2019 - 11/15/2022. N01DA-19-2250.
$511,983Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2019 · DA
Investigating the mechanistic contribution of Cav1.2 channels in extinction of cocaine-associated memories
$511,979Anjali M Rajadhyaksha · Temple Univ Of The Commonwealth · R01 · FY2025 · DA
Reducing the Transition from Acute to Chronic Musculoskeletal Pain among Older Adults
$511,967Michelle Meyer · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AG
Identifying Amphetamine Addiction Risk Variants by Whole Genome Sequencing
$511,863Thorgeir E. Thorgeirsson · Decode Genetics, Ehf · R01 · FY2016 · DA
SBIRT for Substance Abuse in Mental Health Treatment Settings
$511,835Mitchell P Karno · University Of California Los Angeles · R01 · FY2013 · DA
Sharing Qualitative Research Data: Identifying and Addressing Ethical and Practical Barriers
$511,827James M Dubois · Washington University · R01 · FY2019 · HG
Postdoctoral training in tobacco control
$511,817Stanton Arnold Glantz · University Of California, San Francisco · R25 · FY2006 · CA
Physiology and Pharmacology of Brain Reward Circuits
$511,782Carl R. Lupica · National Institute On Drug Abuse · ZIA · FY2011 · DA
Methamphetamine Abuse: Natural History, Treatment Effect
$511,615University Of California Los Angeles · R01 · FY2003 · DA
Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis
$511,565Kathleen L Collins · University Of Michigan At Ann Arbor · R61 · FY2023 · DA
Developing and Testing a Computer-Based Alcohol Use Disorder Recovery System
$511,535David H Gustafson · University Of Wisconsin-Madison · R01 · FY2012 · AA
Therapeutic small molecule modulation of Kv channels
$511,519Geoffrey W Abbott · University Of California-Irvine · R01 · FY2025 · NS
Neurotrophic Mechanisms in Cocaine and Opiate Action
$511,432Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DA
Neurotrophic Mechanisms in Cocaine and Opiate Action
$511,432Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA
Neurotrophic Mechanisms in Cocaine and Opiate Action
$511,432Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DA
Neurotrophic Mechanisms in Cocaine and Opiate Action
$511,432Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DA
Abuse-deterrence and prevention of respiratory depression by an oral opioid analgesic and doxapram combination
$511,409Peter Jeffrey Rix · Quivive Pharma, Inc · R44 · FY2023 · DA
Psychological And Methodological Issues In Substance Abuse Treatment/research
$511,384Kenzie L Preston · National Institute On Drug Abuse · Z01 · FY2008 · DA
Evaluation Of Treatments Of Drug Dependence In HIV Infected Patients
$511,384Kenzie L Preston · National Institute On Drug Abuse · Z01 · FY2008 · DA
PHARMACOKINETICS AND PHARMACODYNAMICS OF NICOTINE
$511,371University Of California San Francisco · R37 · FY2000 · DA
GROUP CBT FOR DEPRESSION AND AOD DISORDERS
$511,346Katherine E Watkins · Rand Corporation · R01 · FY2007 · DA